Results
1
1 companies
Clinuvel Pharmaceuticals
Market Cap: AU$585.8m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$11.67
7D
10.1%
1Y
3.5%
